EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Summary of clinical investigation plan for The DIATEC trial: in-hospital diabetes management by a diabetes team and continuous glucose monitoring or point of care glucose testing – a randomised controlled trial

Mikkel Thor Olsen, Carina Kirstine Klarskov, Ulrik Pedersen-Bjergaard, Katrine Bagge Hansen, Peter Lommer Kristensen

BMC Endocrine Disorders · 2024

DOI: 10.1186/s12902-024-01595-4 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift BMC Endocrine Disorders, 2024. Verfasst von Mikkel Thor Olsen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Nephrology, Copenhagen University Hospital - North Zealand, Hilleroed, Denmark. mikkel.thors@gmail.com. Hauptthemen laut MEDLINE: Continuous Glucose Monitoring, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vissing Fonden, Jascha Fonden, Copenhagen University Hospital North Zealand Research Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Worldwide, up to 20 % of hospitalised patients have diabetes mellitus. In-hospital dysglycaemia increases patient mortality, morbidity, and length of hospital stay. Improved in-hospital diabetes management strategies are needed. The DIATEC trial investigates the effects of an in-hospital diabetes team and operational insulin titration algorithms based on either continuous glucose monitoring (CGM) data or standard point-of-care (POC) glucose testing.

Methods

This is a two-armed, two-site, prospective randomised open-label blinded endpoint (PROBE) trial. We recruit non-critically ill hospitalised general medical and orthopaedic patients with type 2 diabetes treated with basal, prandial, and correctional insulin ( N = 166). In both arms, patients are monitored by POC glucose testing and diabetes management is done by ward nurses guided by in-hospital diabetes teams. In one of the arms, patients are monitored in addition to POC glucose testing by telemetric CGM viewed by the in-hospital diabetes teams only. The in-hospital diabetes teams have operational algorithms to titrate insulin in both arms. Outcomes are in-hospital glycaemic and clinical outcomes.

Discussion

The DIATEC trial will show the glycaemic and clinical effects of in-hospital CGM handled by in-hospital diabetes teams with access to operational insulin titration algorithms in non-critically ill patients with type 2 diabetes. The DIATEC trial seeks to identify which hospitalised patients will benefit from CGM and in-hospital diabetes teams compared to POC glucose testing. This is essential information to optimise the use of healthcare resources before broadly implementing in-hospital CGM and diabetes teams.

Trial registration

Prospectively registered at ClinicalTrials.gov with identification number NCT05803473 on March 27 th 2023.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Continuous Glucose MonitoringDiabetes Mellitus, Type 2AdultFemaleHumansMaleMiddle AgedBlood GlucoseHospitalizationHypoglycemic AgentsInsulinPatient Care TeamPoint-of-Care TestingProspective StudiesRandomized Controlled Trials as TopicMulticenter Studies as Topic

Stichwörter der Autor:innen

Continuous glucose monitoringDiabetesIn-hospitalInpatientRCT

Substanzen

Blood GlucoseHypoglycemic AgentsInsulin

Autor:innen und Institutionen

  • Department of Endocrinology and Nephrology, Copenhagen University Hospital - North Zealand, Hilleroed, Denmark. mikkel.thors@gmail.com.
  • Department of Endocrinology and Nephrology, Copenhagen University Hospital - North Zealand, Hilleroed, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Steno Diabetes Center Copenhagen, Copenhagen University Hospital - Herlev-Gentofte, Herlev, Denmark.

Förderung

  • Vissing Fonden
  • Jascha Fonden
  • Copenhagen University Hospital North Zealand Research Grant
  • Fru Olga Bryde Nielsen Fonden
  • PhD-START-puljen North Zealand Hospital
  • A.P. Møller Fonden til Lægevidenskabens Fremme
  • A & J C Tvergaards Fond
  • Læge Inger Goldmanns Fond

Zitieren

APA

Olsen, M. T., Klarskov, C. K., Pedersen-Bjergaard, U., Hansen, K. B., & Kristensen, P. L. (2024). Summary of clinical investigation plan for The DIATEC trial: in-hospital diabetes management by a diabetes team and continuous glucose monitoring or point of care glucose testing – a randomised controlled trial. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-024-01595-4

Vancouver

Olsen MT, Klarskov CK, Pedersen-Bjergaard U, Hansen KB, Kristensen PL. Summary of clinical investigation plan for The DIATEC trial: in-hospital diabetes management by a diabetes team and continuous glucose monitoring or point of care glucose testing – a randomised controlled trial. BMC Endocrine Disorders. 2024. doi:10.1186/s12902-024-01595-4

BibTeX
@article{Olsen2024,
  author = {Olsen, Mikkel Thor and Klarskov, Carina Kirstine and Pedersen-Bjergaard, Ulrik and Hansen, Katrine Bagge and Kristensen, Peter Lommer},
  title = {Summary of clinical investigation plan for The DIATEC trial: in-hospital diabetes management by a diabetes team and continuous glucose monitoring or point of care glucose testing – a randomised controlled trial},
  journal = {BMC Endocrine Disorders},
  year = {2024},
  doi = {10.1186/s12902-024-01595-4}
}
Kostenlos starten →